| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Sr. VP &CFO
3 companies
Waddill William D. is a Director at ARROWHEAD PHARMACEUTICALS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 8,367 | $67.65 | $566,038.07 | -4.5% | -16.4% | - | |
| Oct 10, 2025 | PTGX Protagonist Therapeutics, Inc | Director | Sale+OE | 12,000 | $81.62 | $979,480.00 | -39.7% | -7.8% | - | |
| Sep 22, 2025 | PTGX Protagonist Therapeutics, Inc | Director | Sell | 4,000 | $64.25 | $257,000.00 | -43.8% | +35.5% | - | |
| Aug 27, 2025 | PTGX Protagonist Therapeutics, Inc | Director | Sell | 4,000 | $59.25 | $237,000.00 | -30.5% | +46.3% | - | |
| Mar 17, 2025 | PTGX Protagonist Therapeutics, Inc | Director | Sell | 4,000 | $54.25 | $217,000.00 | -23.4% | +3.1% | +83.4% | |
| Dec 17, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 7,495 | $21.97 | $164,665.08 | -8.1% | -30.0% | +191.0% | |
| Sep 10, 2024 | PTGX Protagonist Therapeutics, Inc | Director | Sale+OE | 8,000 | $45.00 | $360,000.00 | -40.0% | -9.8% | +28.5% | |
| Jul 24, 2024 | PTGX Protagonist Therapeutics, Inc | Director | Sale+OE | 8,000 | $40.00 | $320,000.00 | -40.0% | +10.9% | +28.3% | |
| Jun 7, 2024 | PTGX Protagonist Therapeutics, Inc | Director | Sale+OE | 8,000 | $35.00 | $280,000.00 | -40.0% | +20.7% | +56.3% | |
| Mar 1, 2024 | PTGX Protagonist Therapeutics, Inc | Director | Sale+OE | 12,975 | $31.34 | $406,636.50 | -52.0% | -13.8% | +16.9% |